Advertisement

The Use of FRAX® in DXA Interpretation

  • S. M. Ploof
  • S. Wuertzer
  • Leon Lenchik
Part of the Medical Radiology book series (MEDRAD)

Abstract

The World Health Organization (WHO) recently developed a fracture risk algorithm (FRAX®) that has fundamentally changed how clinical Dual X-ray Absorptiometry (DXA) scans are interpreted. The impact of FRAX on the community of clinicians who diagnose and treat patients with osteoporosis almost rivals the introduction of the T-score two decades ago. We review the clinical utility of FRAX in this chapter and show how our practice of DXA interpretation and reporting has changed with its introduction.

Keywords

Bone Mineral Density Fracture Risk Osteoporotic Fracture Clinical Risk Factor Femoral Neck Bone Mineral Density 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Baron JA, Karagas M, Barrett J (1996) Basic epidemiology of fractures of the upper and lower limb among Americans over 65 years of age. Epidemiology 7(6):612–618PubMedCrossRefGoogle Scholar
  2. Berg KM, Kunins HV, Jackson JL, Nahvi S, Chaudhry A, Harris KA Jr, Malik R, Arnsten JH (2008) Association between alcohol consumption and both osteoporotic fracture and bone density. Am J Med 121(5):406–418PubMedCrossRefGoogle Scholar
  3. Black DM, Arden NK, Palermo L, Pearson J, Cummings SR (1999) Prevalent vertebral deformities predict hip fractures and new vertebral fractures, but not wrist fractures. J Bone Miner Res 14:821–828PubMedCrossRefGoogle Scholar
  4. Blank RD (2011) Official positions for FRAX® clinical regarding prior fractures from joint official positions development conference of the international society for clinical densitometry and international osteoporosis foundation on FRAX®. J Clin Densitom 14(3):205–211PubMedCrossRefGoogle Scholar
  5. Borgström F, Johnell O, Kanis JA, Jönsson B, Rehnberg C (2006) At what hip fracture risk is it cost-effective to treat? International Intervention thresholds for the treatment of osteoporosis. Osteoporos Int 17:1459–1471PubMedCrossRefGoogle Scholar
  6. Broy SB, Tanner SB (2011) Official positions for FRAX® clinical regarding rheumatoid arthritis. J Clin Densitom 14(3):184–189PubMedCrossRefGoogle Scholar
  7. Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res 22:465–475PubMedCrossRefGoogle Scholar
  8. Center JR, Bliuc D, Nguyen TV, Eisman JA (2007) Risk of subsequent fracture after low-trauma fracture in men and women. J Am Med Assoc 297(4):387–394CrossRefGoogle Scholar
  9. Cornuz J, Feskanich D, Willett WC, Colditz GA (1999) Smoking, smoking cessation, and risk of hip fracture in women. AJM 106(3):311–314CrossRefGoogle Scholar
  10. Cranney A, Jamal SA, Tsang JF, Josse RG, Leslie WD (2007) Low bone mineral density and fracture burden in postmenopausal women. CMAJ 177(6):575–580PubMedGoogle Scholar
  11. Cummings SR, Black DM, Nevitt MC et al (1993) Bone density at various sites for the prediction of hip fractures. Lancet 341:72–75PubMedCrossRefGoogle Scholar
  12. Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE et al (1995) Risk factors for hip fracture in white women. Study of osteoporotic fractures research group. N Engl J Med 332(12):767–773PubMedCrossRefGoogle Scholar
  13. Dasher LG, Newton CD, Lenchik L (2010) Dual X-ray absorptiometry in today’s clinical practice. Radiol Clin North Am 48:541–560PubMedCrossRefGoogle Scholar
  14. De Laet C, Kanis JA, Oden A, Johanson H, Johnell O, Delmas P et al (2005) Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int 16(11):1330–1338PubMedCrossRefGoogle Scholar
  15. de Vries F, Pouwels S, Lammers JW et al (2007) Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case-control study. J Intern Med 261(2):170–177PubMedCrossRefGoogle Scholar
  16. Dimai HP, Chandran M (2011) Official positions for FRAX® clinical regarding smoking. J Clin Densitom 14(3):190–193PubMedCrossRefGoogle Scholar
  17. Ensrud KE, Lui LY, Taylor BC, Schousboe JT, Donaldson MG, Fink HA, Cauley JA, Hillier TA, Browner WS, Cummings SR (2009) A comparison of prediction models for fractures in older women: is more better? Arch Intern Med 169(22):2087–2094PubMedCrossRefGoogle Scholar
  18. Eastell R, Boyle IT, Compston J et al (1998) Management of male osteoporosis: report of the UK consensus group. Q J Med 91:71CrossRefGoogle Scholar
  19. Ettinger B, Ray GT, Pressman AR et al (2003) Limb fractures in elderly men as indicators of subsequent osteoporotic fractures. Arch Intern Med 163(22):2741–2747PubMedCrossRefGoogle Scholar
  20. Felson DT, Zhang Y, Hannan MT, Anderson JJ (1993) Effects of weight and body mass index on bone mineral density in men and women: the Framingham study. J Bone Miner Res 8(5):567–573PubMedCrossRefGoogle Scholar
  21. Giangregorio LM, Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA (2012) FRAX underestimates fracture risk in patients with diabetes. J Bone Miner Res 27(2):301–308PubMedCrossRefGoogle Scholar
  22. Hans DB, Kanis JA, Baim S, Bilenzikian JP, Binkley N et al (2011) Joint official positions of the international society for clinical densitometry and international osteoporosis foundation on FRAX. J Clin Densitom 14(3):171–180PubMedCrossRefGoogle Scholar
  23. Hillier TA, Cauley JA, Rizzo JH, Pedula KL, Ensrud KE, Bauer DC, Lui L, Vesco KK, Black DM, Donaldson MG, LeBlanc ES, Cummings SR (2011) WHO absolute fracture risk models (FRAX): do clinical risk factors improve fracture prediction in older women without osteoporosis? J Bone Miner Res 26(8):1774–1782PubMedCrossRefGoogle Scholar
  24. Høidrup S, Gronbaek M, Gottschau A, Lauritzen JB, Schroll M (1999) Alcohol intake, beverage preference, and risk of hip fracture in men and women. Am J Epidemiol 149(11):993–1001PubMedCrossRefGoogle Scholar
  25. Høidrup S, Prescott E, Sørensen TIA, Gottschau A, Lauritzen JB, Schroll M, Grønbaek M (2000) Tobacco smoking and risk of hip fracture in men and women. Int J Epidemiol 29(2):253–259PubMedCrossRefGoogle Scholar
  26. Joop PW, van den Bergh Tineke ACM, van Geel Lems WF, Geusens PP (2010) Assessment of individual fracture risk: FRAX and beyond. Curr Osteoporos Rep 8:131–137CrossRefGoogle Scholar
  27. Kanis JA, Johnell O, De Laet C et al (2002) International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res 17:1237–1244PubMedCrossRefGoogle Scholar
  28. Kanis JA, Oden A, Johnell O et al (2003) The components of excess mortality after hip fracture. Bone 32:468PubMedCrossRefGoogle Scholar
  29. Kanis JA, Johansson H, Oden A et al (2004a) A family history of fracture and fracture risk: a meta-analysis. Bone 35:1029–1037PubMedCrossRefGoogle Scholar
  30. Kanis JA, Johansson H, Oden A et al (2004b) A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 19:893–899PubMedCrossRefGoogle Scholar
  31. Kanis JA, Johnell O, De Laet C et al (2004c) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35:375–382PubMedCrossRefGoogle Scholar
  32. Kanis JA, Borgstrom F, De Laet C, Johansson H, Johnell O, Jonsson B (2005a) Assessment of fracture risk. Osteoporos Int 16:581–589PubMedCrossRefGoogle Scholar
  33. Kanis JA, Johansson H, Johnell O, Oden A, De Laet C, Eisman JA, Pols H, Tenenhouse A (2005b) Alcohol intake as a risk factor for fracture. Osteoporos Int 16(7):737–742PubMedCrossRefGoogle Scholar
  34. Kanis JA, Johnell O, Oden A et al (2005c) Smoking and fracture risk: a meta-analysis. Osteoporos Int 16:155–162PubMedCrossRefGoogle Scholar
  35. Kanis JA, Oden A, Johnell O et al (2007) The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 18:1033–1046PubMedCrossRefGoogle Scholar
  36. Kanis JA, Burlet N, Cooper C, Delmas PD, Reginster JY, Borgstrom F et al (2008a) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 19(4):399–428PubMedCrossRefGoogle Scholar
  37. Kanis JA, McCloskey EV, Johansson H, Oden A, Melton LJ, Khaltaev N (2008b) A reference standard for the description of osteoporosis. Bone 42:467–475PubMedCrossRefGoogle Scholar
  38. Kanis JA, McCloskey EV, Johansson H, Strom O, Borgstrom F, Oden A (2008c) Case finding for the management of osteoporosis with FRAX®—assessment and intervention thresholds for the UK. Osteoporos Int 19:1395–1408PubMedCrossRefGoogle Scholar
  39. Kanis J, Oden A, Johansson H, Borgström F, Ström O, McCloskey E (2009) FRAX® and its applications to clinical practice. Bone 44:734–743PubMedCrossRefGoogle Scholar
  40. Kanis JA, Johansson H, Oden A et al (2011) Guidance for the adjustment of FRAX according to the dose of glucocorticoids. Osteoporos Int 22:809–816PubMedCrossRefGoogle Scholar
  41. Kanis JA, McCloskey E, Johansson H, Oden A, Leslie WD (2012) FRAX with and without BMD. Calcif Tissue Int 90:1–13PubMedCrossRefGoogle Scholar
  42. Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA III, Berger M (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15(4):721–739PubMedCrossRefGoogle Scholar
  43. Law MR, Hackshaw AK (1997) A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of major effects. BMJ 315(7112):841–846PubMedCrossRefGoogle Scholar
  44. Leib ES, Saag KG, Adachi JD et al (2011) Official positions for FRAX® clinical regarding glucocorticoids: the impact of the use of glucocorticoids on the estimate by FRAX® of the 10 year risk of fracture. J Clin Densitom 14(3):212–219PubMedCrossRefGoogle Scholar
  45. Leslie WD, Lix LM, Tsang JF, Caetano PA (2007) Single-site vs multisite bone density measurement for fracture prediction. Arch Intern Med 167(15):1641–1647PubMedCrossRefGoogle Scholar
  46. Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA (2011) Spine-hip discordance and fracture risk assessment: a physician-friendly FRAX enhancement. Osteoporos Int 22:839–847PubMedCrossRefGoogle Scholar
  47. Leslie WD, Majumdar SR, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA (2012) High fracture probability with FRAX® usually indicates densitometric osteoporosis: implications for clinical practice. Osteoporos Int 23:391–397PubMedCrossRefGoogle Scholar
  48. Lewiecki EM (2010) Fracture risk assessment in clinical practice: T-scores, FRAX, and beyond. Clinic Rev Bone Miner Metab 8:101–112CrossRefGoogle Scholar
  49. Lewiecki EM, Compston JE, Miller PD, Adachi JD et al (2011) Official positions for FRAX® bone mineral density and FRAX® simplification. J Clin Densitom 14(3):226–236PubMedCrossRefGoogle Scholar
  50. Lindsay R, Silverman SL, Cooper C, Hanley DA, Barton I, Broy SB et al (2001) Risk of new vertebral fracture in the year following a fracture. J Am Med Assoc 285:320–323CrossRefGoogle Scholar
  51. Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. Br Med J 312:1254–1259CrossRefGoogle Scholar
  52. Masud T, Morris RO (2001) Epidemiology of falls. Age Ageing 30(4):S9–S16Google Scholar
  53. Masud T, Binkly N, Boonen S, Hannan MT (2011) Official positions for FRAX® clinical regarding falls and frailty: can falls and frailty be used in FRAX®? J Clin Densitom 14(3):194–204PubMedCrossRefGoogle Scholar
  54. McCloskey EV, Johansson H, Oden A, Kanis JA (2009) From relative risk to absolute fracture risk calculation: the FRAX algorithm. Curr Osteoporos Rep 7:77–83PubMedCrossRefGoogle Scholar
  55. Mukamal KJ, Robbins JA, Cauley JA, Kern LM, Siscovick DS (2007) Alcohol consumption, bone density, and hip fracture among older adults: the cardiovascular health study. Osteoporos Int 18(5):593–602PubMedCrossRefGoogle Scholar
  56. National Osteoporosis Foundation (2010) Clinician’s guide to prevention and treatment of osteoporosisGoogle Scholar
  57. National Osteoporosis Guideline Group (2010) Osteoporosis: clinical guideline for prevention and treatmentGoogle Scholar
  58. Pasco JA, Seeman E, Henry MJ, Merriman EN, Nicholson GC, Kotowicz MA (2006) The population burden of fractures originates in women with osteopenia, not osteoporosis. Osteoporos Int 17(9):1404–1409PubMedCrossRefGoogle Scholar
  59. Puisto V, Heliövaara M, Jalanko T, Kröger H, Knekt P, Aromaa A, Rissanen H, Helenius I (2012) Severity of vertebral fracture and risk of hip fracture: a nested case-control study. Osteoporos Int 22:63–69CrossRefGoogle Scholar
  60. Roux C, Thomas T (2009) Optimal use of FRAX®. Joint Bone Spine 76:1–3PubMedCrossRefGoogle Scholar
  61. Roy DK, Pye SR, Lunt M et al (2002) Falls explain between center differences in the incidence of limb fracture across Europe. Bone 31:712–717PubMedCrossRefGoogle Scholar
  62. Sanders KM, Nicholson GC, Watts JJ, Pasco JA, Henry MJ, Kotowicz MA et al (2006) Half the burden of fragility fractures in the community occur in women without osteoporosis: When is fracture prevention cost effective? Bone 38(5):694–700PubMedCrossRefGoogle Scholar
  63. Schousboe JT, Fink HA, Lui LY, Taylor BC, Ensrud KE (2006) Association between prior non-spine non-hip fractures or prevalent radiographic vertebral deformities known to be at least 10 years old and incident hip fracture. J Bone Miner Res 21(10):1557–1564PubMedCrossRefGoogle Scholar
  64. Silverman SL, Calderon AD (2010) The utility and limitations of FRAX: a US perspective. Curr Osteoporos Rep 8:192–197PubMedCrossRefGoogle Scholar
  65. Siris ES, Brenneman SK, Barrett-Connor E, Miller PD, Saijan S, Berger ML, Chen YT (2006) The effect of age and bone mineral density on the absolute, excess, and relative risk of fracture in postmenopausal women aged 50–99: results from the National Osteoporosis Risk Assessment (NORA). Osteoporos Int 17:565–574PubMedCrossRefGoogle Scholar
  66. Tosteson AN, Melton LJ III, Dawson-Hughes B, Baim S, Favus MJ, Khosla S et al (2008) Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int 19(4):437–447PubMedCrossRefGoogle Scholar
  67. Tremollieres FA, Pouille JM, Drewniak N, Laparra J, Ribot C, Dargent-Molina P (2010) Fracture risk prediction using BMD and clinical risk factors in early postmenopausal women: sensitivity of the WHO FRAX tool. J Bone Miner Res 25(5):1002–1009PubMedCrossRefGoogle Scholar
  68. van Staa TP, Leufkens HGM, Abenhaim L, Zhang B, Cooper C (2000a) Use of oral corticosteroids and risk of fractures. J Bone Miner Res 15:993–1000PubMedCrossRefGoogle Scholar
  69. van Staa TP, Leufkens HGM, Abenhaim L, Zhang B, Cooper C (2000b) Oral corticosteroids and fracture risk: relationship to daily and cumulative dosing. Rheumatology 39:1383–1389PubMedCrossRefGoogle Scholar
  70. van Staa TP, Leufkens HG, Cooper C (2002) The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 13(10):777–787PubMedCrossRefGoogle Scholar
  71. van Staa TP, Laan RF, Barton IP, Cohen S, Reid DM, Cooper C (2003) Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum 48:3224–3229PubMedCrossRefGoogle Scholar
  72. Vestergaard P, Mosekilde L (2003) Fracture risk associated with smoking: a meta-analysis. J Intern Med 254(6):572–583PubMedCrossRefGoogle Scholar
  73. Wainwright SA, Marshall LM, Ensrud KE et al (2005) Hip fracture in women without osteoporosis. J Clin Endocrinol Metab 90(5):2787–2793PubMedCrossRefGoogle Scholar
  74. Ward KD, Klesges RC (2001) A meta-analysis of the effects of cigarette smoking on mineral density. Calcif Tissue Int 68:259–270PubMedCrossRefGoogle Scholar
  75. Watts NB, Ettinger B, LeBoff MS (2009) FRAX Facts. J Bone Miner Res 24(6):975–979PubMedCrossRefGoogle Scholar
  76. Weinstein RS (2011) Glucocorticoid-induced bone disease. NEJM 365:62–70PubMedCrossRefGoogle Scholar
  77. Weatherall M, James K, Clay J et al (2008) Dose response relationship for risk of non-vertebral fracture with inhaled corticosteroids. Clin Exp Allergy 38(9):1451–1458PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  1. 1.Department of RadiologyWake Forest University School of MedicineWinston-SalemUSA

Personalised recommendations